FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia-Reference-Cited by-同舟云学术

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Published:2014-02 Issue:2 Volume:20 Page:271-277
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Papadia Cinzia,Louwagie Joost,Del Rio Paolo,Grooteclaes Madeleine,Coruzzi Alessandro,Montana Chiara,Novelli Marco,Bordi Cesare,de’ Angelis Gian Luigi,Bassett Paul,Bigley Joseph,Warren Bryan,Atkin Wendy,Forbes Alastair

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference36 articles.

1. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases

2. At the Crossroads of Inflammation and Cancer

3. Colorectal cancer surveillance in inflammatory bowel disease: The search continues

4. Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study

5. AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Forkhead box E1, frequently downregulted by promoter methylation, inhibits colorectal cancer cell growth and migration;Cancer Cell International;2024-05-11

2. Effects of DNA methylation and its application in inflammatory bowel disease (Review);International Journal of Molecular Medicine;2024-04-30

3. Forkhead box E1, frequently methylated in colorectal cancer, inhibits cancer cell growth and metastasis by changing the cellular actin skeleton;2023-10-10

4. Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer;Frontiers in Immunology;2023-08-21

5. The high expression of FOXE1 in colorectal cancer predicts a promising prognosis: a retrospective study;Clinical and Experimental Medicine;2023-06-06